Novartis Ag (NVS) Non-cash Items (2009 - 2026)

Novartis Ag has reported Non-cash Items for 15 years, with the latest figure at $3.4 billion in Q2 2026.

• Quarterly Non-cash Items rose 14.32% year-over-year to $3.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.6 billion (up 6.32% YoY) and the FY2025 annual result came in at $11.2 billion, up 9.74% from the prior year.
• Non-cash Items improved to $3.4 billion in Q2 2026 per NVS's latest filing, from $3.0 billion in the prior quarter.
• Over five years, Non-cash Items peaked at $4.9 billion in Q4 2024 and troughed at $2.4 billion in Q2 2024.
• A 5-year average of $3.2 billion and a median of $3.0 billion in 2022 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items jumped 61.11% in 2022, then retreated 16.14% in 2023.
• Over 5 years, Non-cash Items stood at $3.1 billion in 2022, then retreated by 16.14% to $2.6 billion in 2023, then jumped by 90.77% to $4.9 billion in 2024, then sank by 39.68% to $3.0 billion in 2025, then rose by 14.32% to $3.4 billion in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $3.4 billion, $3.0 billion, and $4.9 billion for Q2 2026, Q2 2025, and Q4 2024 respectively.